Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Nelson, Monica E.a; * | Andel, Rossa; b; c | Nedelska, Zuzanab; c | Martinkova, Julieb | Cechova, Katerinab; c | Markova, Hanab; c | Matuskova, Veronikab; c | Nikolai, Tomasb; c | Lerch, Ondrejb; c | Parizkova, Martinab; c | Laczo, Janb; c | Vyhnalek, Martinb; c | Hort, Jakubb; c
Affiliations: [a] School of Aging Studies, University of South Florida, Tampa, FL, USA | [b] Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic | [c] International Clinical Research Center, St. Anne’s University Hospital Brno, Brno, Czech Republic
Correspondence: [*] Correspondence to: Monica E. Nelson, MA, 13301 Bruce B. Downs Blvd., MHC 1317, Tampa, FL 33612, USA. Tel.: +1 813 974 3232; E-mail: mnelson10@usf.edu.
Abstract: Background:Identifying modifiable risk factors for cognitive decline can reduce burden of dementia. Objective:We examined whether homocysteine was associated with memory performance, mediated by entorhinal volume, hippocampal volume, total gray matter volume, or white matter lesions, and moderated by APOE ɛ4 allele, B vitamins, creatinine, total cholesterol, or triglycerides. Methods:All 204 members of the Czech Brain Aging Study with subjective cognitive decline (SCD; n = 60) or amnestic mild cognitive impairment (aMCI; n = 144) who had valid data were included. Linear regression was used, followed by conditional process modeling to examine mediation and moderation. Results:Controlling for age, sex, and education, higher homocysteine was related to poorer memory performance overall (b = –0.03, SE = 0.01, p = 0.017) and in participants with SCD (b = –0.06, SE = 0.03, p = 0.029), but less so in aMCI (b = –0.03, SE = 0.02, p = 0.074); though sensitivity analyses revealed a significant association when sample was reduced to aMCI patients with more complete cognitive data (who were also better functioning; b = –0.04, SE = 0.02, p = 0.022). Results were unchanged in fully adjusted models. Neither mediation by markers of brain integrity nor moderation by APOE ɛ4, B vitamins, creatinine, and cardiovascular factors were significant. Memory sub-analyses revealed that results for SCD were likely driven by non-verbal memory. The homocysteine-memory relationship was significant when hippocampal volume was below the median (b = –0.04, SE = 0.02, p = 0.046), but not at/above the median (p = 0.247). Conclusion:Higher homocysteine levels may adversely influence memory performance, which appears particularly apparent in those without cognitive impairment. Results appear to be independent of brain health, suggesting that homocysteine may represent a good target for intervention.
Keywords: Hippocampus, magnetic resonance imaging, mild cognitive impairment, neuropsychological tests
DOI: 10.3233/JAD-201558
Journal: Journal of Alzheimer's Disease, vol. 81, no. 1, pp. 413-426, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl